A recent study showed that ER levels were nonsignificantly higher in women with fibroadenomas than women with either a strong family history without known BRCA mutations or a previous history of cancer suggesting that women at high risk of developing breast cancer do not have higher ER expression than women who are not at higher risk of breast cancer [12]. Here, ESR1 is linked to breast carcinoma.